MP-201
Asset
Slow-release prodrug of 2,4-dinitrophenol that induces mitochondrial uncoupling.
- Stage
- Preclinical
- Modality
- Small molecule
- Target
- Not known
- 6
- Indications
- 0
- Trials
- 1
- Developer
Indications
6Alzheimer's disease
Preclinical, mitochonpharma.com, 10 Oct 2026
Amyotrophic lateral sclerosis
Preclinical, mitochonpharma.com, 10 Oct 2026
Huntington's disease
Preclinical, mitochonpharma.com, 10 Oct 2026
3 more
In the full profile
- Owner and partners1
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.